Health

EPA’s Science Advisory Board offers recommendations to improve cost-benefit analysis.

Proposed federal standards issued for implementing health care reform.

The agency details its plans to enhance transparency, public collaboration.

Hearing discusses how to address potential global crisis.

Nine bold warnings approved for display.

Committee members urge FDA to expedite releasing industry guidance.

The plan would improve collaboration, data management, and resource allocation.

Agencies underestimate the value of human life by consistently ignoring health inflation and wealth inflation.

The bill would prohibit government subsidies for healthcare plans that cover abortions.

Drug approval could signal new era in Hepatitis C treatment.

Proposal strictly defines home and community-based care.

A rare strain of E. coli raises tensions and questions over the EU response.